2019
DOI: 10.1016/j.biopha.2018.11.094
|View full text |Cite
|
Sign up to set email alerts
|

Hypoglycemic activity of the extracts of Belamcanda chinensis leaves (BCLE) on KK-Ay mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
9
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 23 publications
3
9
0
Order By: Relevance
“…PEPCK and G-6-Pase are two rate-limiting enzymes that regulate hepatic gluconeogenesis and accelerate the transformation of glycogen, fat, and protein into glucose. The inhibition of PEPCK and G-6-Pase expression can effectively regulate the increased blood glucose (36, 40), which is consistent with the results of our present study. Lipid peroxidation caused by hyperglycemia induces liver damage in diabetes (41).…”
Section: Discussionsupporting
confidence: 92%
“…PEPCK and G-6-Pase are two rate-limiting enzymes that regulate hepatic gluconeogenesis and accelerate the transformation of glycogen, fat, and protein into glucose. The inhibition of PEPCK and G-6-Pase expression can effectively regulate the increased blood glucose (36, 40), which is consistent with the results of our present study. Lipid peroxidation caused by hyperglycemia induces liver damage in diabetes (41).…”
Section: Discussionsupporting
confidence: 92%
“…The improved insulin sensitivity is achieved by either systemic sensitization of insulin or direct PPAR‐γ action on the transcription of glucose disposal genes, such as Glut‐2, which is one of the downstream target genes of PPAR‐γ. [ 90,91 ] Impaired pancreatic Glut‐2 mRNA expression by an HFD resulted in increased insulin secretion by pancreatic β‐cells in response to hyperglycemia, [ 92 ] subsequently resulting in uncorrected postprandial hyperglycemia. [ 93 ] In the present investigation, Glut‐2 gene expression in the diabetic group was suppressed in parallel with the results of several previous studies.…”
Section: Discussionmentioning
confidence: 99%
“…Diabetes mellitus (DM) is a common and prevalent metabolic disorder characterized by hyperglycemia and abnormal lipid and protein. 1 It is one of the five leading causes death in the world affecting both developed and developing countries alike. It was projected that about 300 million people will have the disease by the year 2025.…”
Section: Introductionmentioning
confidence: 99%
“…7 There are many oral hypoglycemic agents for the management of type-2 diabetes currently, such as biguanides and sulfonylureas, but these synthetic agents are associated with certain adverse side effects (such as hypoglycemia, drug resistance, dropsy and weight gain) and even toxicity. 1,2 In addition, these therapeutic measures have inadequate efficacy or significant mechanism-based adverse effect when used as a combined therapy. Hence, there is need for drug that has fewer side effects and elicit less hypersensitivity with high anti-diabetic regulations.…”
Section: Introductionmentioning
confidence: 99%